Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Jaffe

Showing results (21-30 of 164) with videos related to

Pageof 17
Sort By:
Pharmacotherapy|September 1, 1982
The use of intravenous nitroglycerin in cardiovascular diseaseA S Jaffe, R Roberts
British Journal of Anaesthesia|March 31, 2015
'Paradox' of troponin elevations after non-cardiac surgeryG Landesberg, A S Jaffe
Circulation|March 1, 1995
What is the true periprocedure myocardial infarction rate? Does anyone know for sure? The need for clarificationB R Chaitman, A S Jaffe
Circulation|November 28, 2001
Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) studyF S Apple, A S Jaffe
Cardiology Clinics|February 1, 1987
Coronary thrombolysis: practical considerationsP R Eisenberg, A S Jaffe
Clinical Chemistry|November 1, 1986
Increased creatine kinase MB in the absence of acute myocardial infarctionG F Pierce, A S Jaffe
Neurology|November 1, 1993
Death after death: the presumption of informed consent for cardiopulmonary resuscitation--ethical paradox and clinical conundrumA S Jaffe, W M Landau
Heart Disease and Stroke : a Journal for Primary Care Physicians|January 1, 1993
The value and limitations of cardiac enzymes in the recognition of acute myocardial infarctionB E Sobel, A S Jaffe
Catheterization and Cardiovascular Diagnosis|March 1, 1987
Hemodynamic monitoring and pacing with one catheter: a pilot studyC J Gessler, A S Jaffe
JAMA|January 10, 1986
Thrombolysis with tissue-type plasminogen activator in acute myocardial infarction. Potentials and pitfallsA S Jaffe, B E Sobel
Pageof 17

Showing results (21-30 of 164) with videos related to

Sort By:
Pageof 17
Pharmacotherapy|September 1, 1982
The use of intravenous nitroglycerin in cardiovascular diseaseA S Jaffe, R Roberts
British Journal of Anaesthesia|March 31, 2015
'Paradox' of troponin elevations after non-cardiac surgeryG Landesberg, A S Jaffe
Circulation|March 1, 1995
What is the true periprocedure myocardial infarction rate? Does anyone know for sure? The need for clarificationB R Chaitman, A S Jaffe
Circulation|November 28, 2001
Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) studyF S Apple, A S Jaffe
Cardiology Clinics|February 1, 1987
Coronary thrombolysis: practical considerationsP R Eisenberg, A S Jaffe
Clinical Chemistry|November 1, 1986
Increased creatine kinase MB in the absence of acute myocardial infarctionG F Pierce, A S Jaffe
Neurology|November 1, 1993
Death after death: the presumption of informed consent for cardiopulmonary resuscitation--ethical paradox and clinical conundrumA S Jaffe, W M Landau
Heart Disease and Stroke : a Journal for Primary Care Physicians|January 1, 1993
The value and limitations of cardiac enzymes in the recognition of acute myocardial infarctionB E Sobel, A S Jaffe
Catheterization and Cardiovascular Diagnosis|March 1, 1987
Hemodynamic monitoring and pacing with one catheter: a pilot studyC J Gessler, A S Jaffe
JAMA|January 10, 1986
Thrombolysis with tissue-type plasminogen activator in acute myocardial infarction. Potentials and pitfallsA S Jaffe, B E Sobel
Pageof 17